Table 3.

Overall survival data (%) for IDO-positive and IDO-negative AML samples.

Study	Years	Overall survival of patients (%)
		IDO-positive	IDO-negative
Folgiero et al. (19)	8	31.6	63
Fukuno et al. (20)	3	39	74
Hara at el. (27)	3	37	77